215 related articles for article (PubMed ID: 33926892)
21. Non-communicable diseases, sociodemographic vulnerability and the risk of mortality in hospitalised children and adolescents with COVID-19 in Brazil: a cross-sectional observational study.
Sousa BLA; Brentani A; Costa Ribeiro CC; Dolhnikoff M; Grisi SJFE; Ferrer APS; Ferraro AA
BMJ Open; 2021 Sep; 11(9):e050724. PubMed ID: 34489291
[TBL] [Abstract][Full Text] [Related]
22. Time-varying associations between COVID-19 case incidence and community-level sociodemographic, occupational, environmental, and mobility risk factors in Massachusetts.
Tieskens KF; Patil P; Levy JI; Brochu P; Lane KJ; Fabian MP; Carnes F; Haley BM; Spangler KR; Leibler JH
BMC Infect Dis; 2021 Jul; 21(1):686. PubMed ID: 34271870
[TBL] [Abstract][Full Text] [Related]
23. Associations of Race/Ethnicity and Food Insecurity With COVID-19 Infection Rates Across US Counties.
Kimani ME; Sarr M; Cuffee Y; Liu C; Webster NS
JAMA Netw Open; 2021 Jun; 4(6):e2112852. PubMed ID: 34100936
[TBL] [Abstract][Full Text] [Related]
24. Understanding the differential impacts of COVID-19 among hospitalised patients in South Africa for equitable response.
Phaswana-Mafuya N; Shisana O; Jassat W; Baral SD; Makofane K; Phalane E; Zuma K; Zungu N; Chadyiwa M
S Afr Med J; 2021 Nov; 111(11):1084-1091. PubMed ID: 34949274
[TBL] [Abstract][Full Text] [Related]
25. Hospitalizations and Mortality From Non-SARS-CoV-2 Causes Among Medicare Beneficiaries at US Hospitals During the SARS-CoV-2 Pandemic.
Dang A; Thakker R; Li S; Hommel E; Mehta HB; Goodwin JS
JAMA Netw Open; 2022 Mar; 5(3):e221754. PubMed ID: 35262712
[TBL] [Abstract][Full Text] [Related]
26. Social inequalities and COVID-19 mortality in the city of São Paulo, Brazil.
Ribeiro KB; Ribeiro AF; Veras MASM; de Castro MC
Int J Epidemiol; 2021 Jul; 50(3):732-742. PubMed ID: 33657223
[TBL] [Abstract][Full Text] [Related]
27. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
[TBL] [Abstract][Full Text] [Related]
28. Characterization of demographic data, clinical signs, comorbidities, and outcomes according to the race in hospitalized individuals with COVID-19 in Brazil: An observational study.
Sansone NM; Boschiero MN; Valencise FE; Palamim CV; Marson FA
J Glob Health; 2022 Jul; 12():05027. PubMed ID: 35871427
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.
de Lusignan S; Dorward J; Correa A; Jones N; Akinyemi O; Amirthalingam G; Andrews N; Byford R; Dabrera G; Elliot A; Ellis J; Ferreira F; Lopez Bernal J; Okusi C; Ramsay M; Sherlock J; Smith G; Williams J; Howsam G; Zambon M; Joy M; Hobbs FDR
Lancet Infect Dis; 2020 Sep; 20(9):1034-1042. PubMed ID: 32422204
[TBL] [Abstract][Full Text] [Related]
30. Racial Disparities in COVID-19 Testing and Outcomes : Retrospective Cohort Study in an Integrated Health System.
Escobar GJ; Adams AS; Liu VX; Soltesz L; Chen YI; Parodi SM; Ray GT; Myers LC; Ramaprasad CM; Dlott R; Lee C
Ann Intern Med; 2021 Jun; 174(6):786-793. PubMed ID: 33556278
[TBL] [Abstract][Full Text] [Related]
31. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
Buonafine CP; Paiatto BNM; Leal FB; de Matos SF; de Morais CO; Guerra GG; Martuchelli MVV; Oliveira DBL; Durigon EL; Soares CP; Candido ED; Telezynski BL; Sáfadi MAP; Almeida FJ
BMC Infect Dis; 2020 Dec; 20(1):917. PubMed ID: 33267836
[TBL] [Abstract][Full Text] [Related]
32. Racial disparities in knowledge, attitudes and practices related to COVID-19 in the USA.
Alobuia WM; Dalva-Baird NP; Forrester JD; Bendavid E; Bhattacharya J; Kebebew E
J Public Health (Oxf); 2020 Aug; 42(3):470-478. PubMed ID: 32490519
[TBL] [Abstract][Full Text] [Related]
33. Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19: Findings From the American Heart Association's COVID-19 Cardiovascular Disease Registry.
Rodriguez F; Solomon N; de Lemos JA; Das SR; Morrow DA; Bradley SM; Elkind MSV; Williams JH; Holmes D; Matsouaka RA; Gupta D; Gluckman TJ; Abdalla M; Albert MA; Yancy CW; Wang TY
Circulation; 2021 Jun; 143(24):2332-2342. PubMed ID: 33200953
[TBL] [Abstract][Full Text] [Related]
34. Hospitalization and Mortality among Black Patients and White Patients with Covid-19.
Price-Haywood EG; Burton J; Fort D; Seoane L
N Engl J Med; 2020 Jun; 382(26):2534-2543. PubMed ID: 32459916
[TBL] [Abstract][Full Text] [Related]
35. Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.
Bassett MT; Chen JT; Krieger N
PLoS Med; 2020 Oct; 17(10):e1003402. PubMed ID: 33079941
[TBL] [Abstract][Full Text] [Related]
36. Cross-sectional study for COVID-19-related mortality predictors in a Brazilian state-wide landscape: the role of demographic factors, symptoms and comorbidities.
Gustani-Buss EG; Buss CE; Cavalli LR; Panis C; Tuon FF; Telles JP; Follador FAC; Wendt GW; Lucio LC; Ferreto LED; de Oliveira IM; Carraro E; David LE; Simão ANC; Boldt ABW; Luiza Petzl-Erler M; Silva WA; Figueiredo DLA
BMJ Open; 2022 Oct; 12(10):e056801. PubMed ID: 36253047
[TBL] [Abstract][Full Text] [Related]
37. Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil.
Rezende LFM; Thome B; Schveitzer MC; Souza-Júnior PRB; Szwarcwald CL
Rev Saude Publica; 2020; 54():50. PubMed ID: 32491091
[TBL] [Abstract][Full Text] [Related]
38. Racial and socioeconomic disparities in multimorbidity and associated healthcare utilisation and outcomes in Brazil: a cross-sectional analysis of three million individuals.
Hone T; Stokes J; Trajman A; Saraceni V; Coeli CM; Rasella D; Durovni B; Millett C
BMC Public Health; 2021 Jul; 21(1):1287. PubMed ID: 34210313
[TBL] [Abstract][Full Text] [Related]
39. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 treatment resource disparities and social disadvantage in New York City.
Douglas JA; Subica AM
Prev Med; 2020 Dec; 141():106282. PubMed ID: 33035550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
